ELEV(Delisted)
Elevation Oncology·NASDAQ
--
--(--)
ELEV fundamentals
During Q1 2025, Elevation Oncology (ELEV) reported revenue of --, a YoY change of 0.00%. Net income was -14.21M, a YoY change of -32.73%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 1.96M -- | 3.42M -- | 3.01M -- | 8.89M -- | 5.09M +159.62% | 5.06M +48.01% | 12.28M +307.60% | 9.62M +8.29% | 17.37M +241.49% | 20.11M +297.57% | 38.53M +213.85% | 18.54M +92.61% | 16.75M -3.59% | 9.83M -51.11% | 10.92M -71.66% | 7.95M -57.13% | 9.87M -41.06% | 10.96M +11.48% | 13.23M +21.14% | -- -- | -- -- | -- -- |
Selling, General and Administrative Expenses | 471.00K -- | 414.00K -- | 462.00K -- | 453.00K -- | 952.00K +102.12% | 1.15M +176.57% | 2.98M +544.81% | 3.38M +645.03% | 3.79M +298.42% | 3.81M +233.01% | 4.19M +40.68% | 4.04M +19.56% | 4.35M +14.58% | 3.81M -0.21% | 3.50M -16.54% | 3.25M -19.33% | 3.86M -11.23% | 4.41M +15.95% | 3.84M +9.81% | -- -- | -- -- | -- -- |
Research and Development Expenses | 1.49M -- | 3.00M -- | 2.55M -- | 8.43M -- | 4.13M +177.82% | 3.91M +30.29% | 9.30M +264.63% | 6.25M -25.91% | 13.57M +228.37% | 16.30M +316.45% | 34.34M +269.33% | 14.50M +132.07% | 7.29M -46.28% | 6.03M -63.01% | 7.42M -78.39% | 4.69M -67.65% | 6.01M -17.57% | 6.55M +8.66% | 9.39M +26.49% | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 5.11M -- | -- -- | -- -- | 0 -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -1.96M -- | -3.42M -- | -3.01M -- | -8.89M -- | -5.09M -159.62% | -5.06M -48.01% | -12.28M -307.60% | -9.62M -8.29% | -17.37M -241.49% | -20.11M -297.57% | -38.53M -213.85% | -18.54M -92.61% | -16.75M +3.59% | -9.83M +51.11% | -10.92M +71.66% | -7.95M +57.13% | -9.87M +41.06% | -10.96M -11.48% | -13.23M -21.14% | -- -- | -- -- | -- -- |
Non-Operating Income (Loss) | 1.00K -- | 12.00K -- | 1.00K -- | -3.00K -- | -5.00K -600.00% | 0 -100.00% | 10.00K +900.00% | 2.00K +166.67% | 93.00K +1960.00% | 187.00K -- | -306.00K -3160.00% | -480.00K -24100.00% | -309.00K -432.26% | -271.00K -244.92% | 295.00K +196.41% | 56.00K +111.67% | -827.00K -167.64% | 513.00K +289.30% | 360.00K +22.03% | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 1.00K -- | 12.00K -- | 1.00K -- | -3.00K -- | -5.00K -600.00% | 0 -100.00% | 10.00K +900.00% | 2.00K +166.67% | 93.00K +1960.00% | 187.00K -- | -306.00K -3160.00% | -480.00K -24100.00% | -- -- | -- -- | -- -- | -229.00K +52.29% | -942.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 309.00K -- | 271.00K -- | -295.00K -- | -285.00K -- | -115.00K -137.22% | -513.00K -289.30% | -360.00K -22.03% | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -1.96M -- | -3.41M -- | -3.01M -- | -8.89M -- | -5.09M -160.01% | -5.06M -48.53% | -12.27M -307.41% | -9.62M -8.23% | -17.27M -239.32% | -19.93M -293.87% | -38.84M -216.60% | -19.02M -97.64% | -17.05M +1.28% | -10.11M +49.29% | -10.63M +72.64% | -7.89M +58.51% | -10.70M +37.28% | -10.45M -3.41% | -12.87M -21.12% | -10.43M -32.15% | -14.21M -32.81% | -47.95M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 25.00K -- | 5.00K -- | 5.00K -- | 11.00K -- | 9.00K -64.00% | 11.00K +120.00% | 11.00K +120.00% | 12.00K +9.09% | 9.00K -- | 6.00K -45.45% | 38.00K -- |
Net Income | -1.96M -- | -3.41M -- | -3.01M -- | -8.89M -- | -5.09M -160.01% | -5.06M -48.53% | -12.27M -307.41% | -9.62M -8.23% | -17.27M -239.32% | -19.93M -293.87% | -38.84M -216.60% | -19.04M -97.90% | -17.06M +1.25% | -10.11M +49.26% | -10.64M +72.61% | -7.90M +58.52% | -10.71M +37.24% | -10.46M -3.47% | -12.88M -21.11% | -10.44M -32.12% | -14.21M -32.73% | -47.99M -- |
Net Income Attributable to Owners of the Company | -1.96M -- | -3.41M -- | -3.01M -- | -8.89M -- | -5.09M -160.01% | -5.06M -48.53% | -12.27M -307.41% | -9.62M -8.23% | -17.27M -239.32% | -19.93M -293.87% | -38.84M -216.60% | -19.04M -97.90% | -17.06M +1.25% | -10.11M +49.26% | -10.64M +72.61% | -7.90M +58.52% | -10.71M +37.24% | -10.46M -3.47% | -12.88M -21.11% | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -1.96M -- | -3.41M -- | -3.01M -- | -8.89M -- | -5.09M -160.01% | -5.06M -48.53% | -12.27M -307.41% | -9.62M -8.23% | -17.27M -239.32% | -19.93M -293.87% | -38.84M -216.60% | -19.04M -97.90% | -17.06M +1.25% | -10.11M +49.26% | -10.64M +72.61% | -7.90M +58.52% | -10.71M +37.24% | -10.46M -3.47% | -12.88M -21.11% | -- -- | -- -- | -- -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | -204.00K -- | -71.00K -- | 17.00K -- | 97.00K -- | 110.00K +153.92% | 49.00K +169.01% | 1.00K -94.12% | 10.00K -89.69% | -9.00K -108.18% | -26.00K -153.06% | 154.00K +15300.00% | -67.00K -770.00% | -50.00K -455.56% | 11.00K -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -5.09M -- | -5.06M -- | -12.27M -- | -9.62M -- | -17.48M -243.33% | -20.00M -295.28% | -38.82M -216.46% | -18.95M -96.89% | -16.95M +3.03% | -10.06M +49.69% | -10.63M +72.60% | -7.89M +58.36% | -10.72M +36.78% | -10.49M -4.23% | -12.73M -19.67% | -10.50M -33.13% | -14.26M -33.08% | -47.98M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -5.09M -- | -5.06M -- | -12.27M -- | -9.62M -- | -17.48M -243.33% | -20.00M -295.28% | -38.82M -216.46% | -18.95M -96.89% | -16.95M +3.03% | -10.06M +49.69% | -10.63M +72.60% | -7.89M +58.36% | -10.72M +36.78% | -10.49M -4.23% | -12.73M -19.67% | -- -- | -- -- | -- -- |
Basic EPS | -2.48 -- | -4.32 -- | -3.8 -- | -- -- | -6.36 -156.45% | -4.84 -12.04% | -0.53 +86.05% | -0.41 -- | -0.74 +88.36% | -0.86 +82.23% | -1.67 -215.09% | -0.82 -100.00% | -0.72 +2.70% | -0.36 +58.14% | -0.23 +86.23% | -0.19 +76.83% | -0.21 +70.83% | -0.18 +50.00% | -0.22 +4.35% | -0.18 +5.26% | -0.24 -14.29% | -0.82 -- |
Diluted EPS | -2.48 -- | -4.32 -- | -3.8 -- | -- -- | -6.36 -156.45% | -4.84 -12.04% | -0.53 +86.05% | -- -- | -0.74 +88.36% | -0.86 +82.23% | -1.67 -215.09% | -- -- | -0.72 +2.70% | -0.36 +58.14% | -0.23 +86.23% | -- -- | -0.21 +70.83% | -0.18 +50.00% | -0.22 +4.35% | -- -- | -0.24 -14.29% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
